University of California, San Francisco
The University of California, San Francisco (UCSF) is a prominent educational institution established in 1897, specializing in health sciences. It offers a range of programs across various fields, including biological, biomedical, pharmaceutical, nursing, social and behavioral sciences, dentistry, and medicine. UCSF comprises several schools, including the School of Medicine, School of Dentistry, School of Nursing, School of Pharmacy, and Continuing Medical Education. The university is known for its significant contributions to research and development, particularly in areas such as advanced cytometry, automated digital pathology, and single-cell genomics. With an endowment of $873 million, UCSF supports a robust academic and research environment, fostering innovation and the advancement of medical technologies. The institution has successfully secured over $40 million in extramural funding for its research initiatives, further enhancing its capabilities and impact in the biomedical field.
ArsenalBio
Series B in 2022
ArsenalBio is a programmable cell therapy company established in 2019, focused on developing effective and accessible immune cell therapies, primarily targeting cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create a new paradigm for discovering and developing immune cell therapies. ArsenalBio's innovative approach aims to enhance the efficacy and safety of T-cell therapies while reducing costs for providers and broadening patient access. By employing a full-stack research and development engine, ArsenalBio generates multifunctional T-cell medicines through the precise insertion of large synthetic DNA sequences, enabling clinicians to utilize next-generation autologous T-cell therapies to combat cancer more effectively.
Hazel Health
Series C in 2020
Hazel Health, Inc. is a healthcare company focused on enhancing access to healthcare services for K-12 students. Founded in 2015 and based in San Francisco, the company provides a telehealth platform that allows students to consult with healthcare professionals through live video, whether they are at school or at home. By partnering with schools and school nurses, Hazel Health aims to improve the health and well-being of students, ensuring they remain healthy and prepared to learn. The platform addresses a variety of physical and behavioral health conditions, enabling doctors to prescribe over-the-counter medications at school with parental consent or call in prescriptions as needed. Hazel Health was previously known as HippoMD, Inc. before rebranding in September 2017.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.